| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HTBI | Common Stock | Options Exercise | $32.5K | +2.27K | +3.59% | $14.37 | 65.3K | Jan 30, 2023 | Direct | F1 |
| transaction | HTBI | Common Stock | Sale | -$60.5K | -2.27K | -3.47% | $26.70 | 63.1K | Jan 30, 2023 | Direct | F1, F2, F3 |
| transaction | HTBI | Common Stock | Options Exercise | $99K | +6.89K | +10.92% | $14.37 | 70K | Jan 31, 2023 | Direct | |
| transaction | HTBI | Common Stock | Sale | -$170K | -6.37K | -9.1% | $26.64 | 63.6K | Jan 31, 2023 | Direct | F2, F4 |
| transaction | HTBI | Common Stock | Sale | -$14K | -520 | -0.82% | $27.00 | 63.1K | Jan 31, 2023 | Direct | F2 |
| holding | HTBI | Common Stock | 5.49K | Jan 30, 2023 | By KSOP |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HTBI | Stock Option | Options Exercise | $0 | -2.27K | -13.62% | $0.00 | 14.4K | Jan 30, 2023 | Common Stock | 2.27K | $14.37 | Direct | F1, F7 |
| transaction | HTBI | Stock Option | Options Exercise | $0 | -6.89K | -47.94% | $0.00 | 7.48K | Jan 31, 2023 | Common Stock | 6.89K | $14.37 | Direct | F7 |
| holding | HTBI | Stock Option | 10K | Jan 30, 2023 | Common Stock | 10K | $31.35 | Direct | F5 | |||||
| holding | HTBI | Stock Option | 40K | Jan 30, 2023 | Common Stock | 40K | $26.00 | Direct | F6 | |||||
| holding | HTBI | Stock Option | 20K | Jan 30, 2023 | Common Stock | 20K | $24.95 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The purpose of this amendment is to correct the original Form 4, which reported that on January 30, 2023, the reporting person acquired 4,250 shares upon the exercise of a stock option and sold those shares. As reflected in this amendment, the number of shares acquired and sold on January 30, 2023 was 2,265, not 4,250, and the information in Table I and Table II has been corrected accordingly. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022. |
| F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.63 to $26.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4 to this Form 4. |
| F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.50 to $26.95, inclusive. |
| F5 | Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2023, 2024, 2025, 2026 and 2027. |
| F6 | Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2019, 2020, 2021, 2022 and 2023. |
| F7 | Represents stock option granted under Issuer's 2013 Omnibus Incentive Plan with the following vesting schedule: 20% increments on February 11, 2014, 2015, 2016, 2017 and 2018. |